4种慢性乙型肝炎治疗方案的成本-效果分析 |
投稿时间:2004-06-15 点此下载全文 |
引用本文:劳国琴,唐志华,王佳良.4种慢性乙型肝炎治疗方案的成本-效果分析[J].药学实践杂志,2004,(6):374~376 |
摘要点击次数: 959 |
全文下载次数: 921 |
|
|
中文摘要:目的 探讨不同药物治疗方案对同一种疾病所产生的效果。方法 运用药物经济学成本-效果分析方法对4种慢性乙型肝炎治疗方案(A-苦参素注射液、B-拉米夫定+胸腺肽、C-干扰素、D-拉米夫定)进行回顾性分析评价。结果 4种方案的有效率分别为74.14%、91.25%、82.86%、83.33%;不良反应发生率分别为12.07%、8.75%、38.57%、1.39%;成本-效果比分别为88.83、134.89、174.11、91.03。结论 D方案为最佳治疗方案。 |
中文关键词:药物经济学 成本-效果分析 慢性乙型肝炎 |
|
Cost-effectiveness analysis of 4 therapeutic schemes for chronic hepatitis B |
|
|
Abstract:Objective To evaluate the economic effectiveness of different drug therapeutic schemes for the same disease.Methods Using pharmacoeconomical cost-effectiveness analysis,four therapeutic schemes for chronic hepatitis B (A-alkoloids sophora injection, B-lamivudine + thymosin, C-interferon, D-lamivudine) were compared.Results The effective rates of four groups were 74.14%, 91.25%,82.86% and 83.33% respectively; The adverse drug reaction rates were 12.07%,8.75%,38.57% and 1.39%.And the cos-effectiveness ratios were respectively 88.83,134.89,174.11 and 91.03.Conclusion Schemes D are the best one. |
keywords:pharmacoeconomics cost-effect analysis chronic hepatitis B |
查看全文 查看/发表评论 下载PDF阅读器 |
|
关闭 |
|
|
|